Literature DB >> 32764114

Long-term trends of asthma, allergic rhinitis and atopic eczema in young Finnish men: a retrospective analysis, 1926-2017.

Jere Reijula1,2, Jari Latvala3, Mika Mäkelä4, Simo Siitonen5, Mari Saario5, Tari Haahtela4.   

Abstract

The aim of this study was to assess the long-term time trends of the prevalence of asthma, allergic rhinitis and atopic eczema in young Finnish men.A retrospective analysis was carried out on cross-sectional data from the Finnish Defence Forces taken from call-up examinations of candidates for military conscription and examinations of conscripts discharged from service because of poor health. Roughly 1.7 million men aged 18‒19 years (98% of men of conscription age) were examined from 1966 to 2017. A proportional but unknown number of young men were examined from 1926 to 1961.The main outcome measures were asthma recorded at call-up examination as the main diagnosis in 1926‒2017 and any diagnosis in 1997‒2017, exemption or discharge from military service due to asthma, and allergic rhinitis and atopic eczema recorded as the main diagnosis in 1966‒2017 and any diagnosis in 1997‒2017.During 1926-1961 the prevalence of asthma remained low at between 0.02% and 0.08%. A linear rise began between 1961 and 1966, with a 12-fold increase in the prevalence from 0.29% in 1966 to 3.44% in 2001. Thereafter, the prevalence of asthma as the main diagnosis stabilised but continued to increase to 5.19% in 2017 if secondary diagnoses of asthma were included. Exemption rates from military service due to asthma have similarly increased but fluctuated more. The prevalence of allergic rhinitis increased from 0.06% to 10.70% and atopic eczema from 0.15% to 2.90% during the period 1966‒2017.In Finland, an increase in asthma and allergic conditions among young men became evident in the mid-1960s. The increase slowed in the 2000s and may be levelling off in the 2020s.
Copyright ©ERS 2020.

Entities:  

Mesh:

Year:  2020        PMID: 32764114     DOI: 10.1183/13993003.02144-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I.

Authors:  David P Strachan; Charlotte E Rutter; Monica Innes Asher; Karen Bissell; Chen-Yuan Chiang; Asma El Sony; Eamon Ellwood; Philippa Ellwood; Luis García-Marcos; Guy B Marks; Eva Morales; Kevin Mortimer; Neil Pearce; Virginia Pérez-Fernández; Steven Robertson; Richard J Silverwood
Journal:  Pediatr Allergy Immunol       Date:  2021-09-21       Impact factor: 5.464

2.  Nasal Bacterial Microbiome Differs Between Healthy Controls and Those With Asthma and Allergic Rhinitis.

Authors:  Meiping Chen; Shiyi He; Phoebe Miles; Chunlin Li; Yijun Ge; Xuechan Yu; Linfeng Wang; Weina Huang; Xue Kong; Shanni Ma; Yiting Li; Qingwen Jiang; Wen Zhang; Chao Cao
Journal:  Front Cell Infect Microbiol       Date:  2022-03-03       Impact factor: 5.293

3.  Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial.

Authors:  Ting Liu; Bing-Qing Lu; Dan-Dan Wang; Chao Liao; Han-Jen Chiang; Rong Zhang; Yuan Xi; Li Tian
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

Review 4.  Managing the allergy and asthma epidemic in 2020s-Lessons from the Finnish experience.

Authors:  Tari Haahtela; Juha Jantunen; Kimmo Saarinen; Erja Tommila; Erkka Valovirta; Tuula Vasankari; Mika J Mäkelä
Journal:  Allergy       Date:  2022-03-09       Impact factor: 14.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.